✦ LIBER ✦

Dalcetrapib in High-Risk Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome

✍ Scribed by Michael H. Davidson; Anton F.H. Stalenhoef; Jennifer G. Robinson; Regina Duttlinger-Maddux; David Kallend; Harold Bays

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Tolerability of Dalcetrapib i

✍ Anne Carol Goldberg; Anton F.H. Stalenhoef; Regina Duttlinger-Maddux; David Kall 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 275 KB

Efficacy and safety of dalcetrapib in ty

✍ A. F. H. Stalenhoef; M. H. Davidson; J. G. Robinson; T. Burgess; R. Duttlinger-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

126 CARDIOVASCULAR RISK IN PATIENTS WITH

✍ Millan, J.; Calzado, C. Garcia; Recarte, C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Cardiovascular risk assessment in patien

✍ Gungor Kanbak; Aysen Akalin; Ali Dokumacioglu; Eda Ozcelik; Cengiz Bal 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 136 KB

Laparoscopic treatment of metabolic synd

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Laparoscopic treatment of metabolic synd

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB